Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 2/20 | 0.62 |
| ▸ | CTSK | P43235 | 2/20 | 0.62 |
| ▸ | CTSV | O60911 | 1/20 | 0.62 |
| ▸ | CTSL | P07711 | 1/20 | 0.62 |
| ▸ | CTSB | P07858 | 1/20 | 0.62 |
| ▸ | ELANE | P08246 | 1/20 | 0.62 |
| ▸ | CMA1 | P23946 | 1/20 | 0.62 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.62 |
| ▸ | F13A1 | P00488 | 1/20 | 0.40 |
| ▸ | TGM2 | P21980 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13689653 | 1.00 | CTSS (0.62) | CTSSCTSKCTSVCTSLCTSB | |
| SCHEMBL10140520 | 1.00 | CTSS (0.62) | CTSSCTSKCTSVCTSLCTSB | |
| SCHEMBL13689676 | 1.00 | CTSS (0.62) | CTSSCTSKCTSVCTSLCTSB | |
| SCHEMBL8354732 | 0.99 | CTSS (0.64) | CTSSCTSKCTSVCTSLCTSB | |
| SCHEMBL10226899 | 0.99 | CTSS (0.64) | CTSSCTSKCTSVCTSLCTSB | |
| SCHEMBL8355281 | 0.99 | CTSS (0.64) | CTSSCTSKCTSVCTSLCTSB | |
| SCHEMBL13688788 | 0.99 | CTSS (0.64) | CTSSCTSKCTSVCTSLCTSB | |
| SCHEMBL8256281 | 0.99 | CTSS (0.64) | CTSSCTSKCTSVCTSLCTSB | |
| SCHEMBL10140255 | 0.98 | CTSV (0.60) | CTSSCTSKCTSVCTSLCTSB | |
| SCHEMBL16329059 | 0.98 | CTSV (0.60) | CTSSCTSKCTSVCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE43298-E1 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION (US) | 2012-04-03 | — | — | US | disclosed |
| US-RE43298-E1 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION (US) | 2012-04-03 | — | — | US | disclosed |
| US-7244721-B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION (US) | 2007-07-17 | — | — | US | disclosed |
| US-7244721-B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION (US) | 2007-07-17 | — | — | US | disclosed |